Efficacy of adjuvant trastuzumab in women with HER2-positive T1a or bN0M0 breast cancer: a population-based cohort study.Published in:Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05209-8By:Ali, Sanji;Hendry, Jace;Le, Duc;Mondal, Prosanta K.;Sami, Amer;Chalchal, Haji;Haider, Kamal;Ahmed, Osama;El-Gayed, Ali;Wright, Philip;Pauls, Mehrnoosh;Johnson, Kate;Ahmed, ShahidPublication type:Article